Related Experiment Video
Updated: May 7, 2025

04:47
Author Spotlight: Controlled Human Exposure Model for Tick Research and Lyme Disease Studies
Published on: December 1, 2023
427
Tularemia - United States, 2011-2022.
MMWR. Morbidity and Mortality Weekly Report
|December 30, 2024
Summary
Tularemia, a rare zoonotic disease caused by Francisella tularensis, saw increased incidence in the U.S. from 2011-2022. Targeted education for prevention and healthcare providers is crucial for reducing tularemia cases and improving outcomes.
Area of Science:
- Zoonotic Diseases
- Infectious Disease Epidemiology
- Public Health Surveillance
Background:
- Tularemia, caused by Francisella tularensis, is a nationally notifiable zoonosis reported across the U.S., except Hawaii.
- Clinical signs vary by infection route, with a case fatality rate typically under 2%, treatable with antibiotics.
Purpose of the Study:
- To analyze national tularemia surveillance data from 2011-2022.
- To identify trends, high-incidence populations, and geographic hotspots for tularemia in the U.S.
Main Methods:
- Analysis of national surveillance data for tularemia cases reported between 2011 and 2022.
- Calculation of incidence rates by age, race/ethnicity, and geographic location.
- Comparison of incidence rates with the previous decade (2001-2010).
Main Results:
- A 56% increase in average annual tularemia incidence was observed from 2011-2022 compared to 2001-2010, largely due to increased probable case reporting.
- Four central states (Arkansas, Kansas, Missouri, Oklahoma) accounted for 50% of cases.
- Highest incidence occurred in children (5-9 years) and older adult males (65-84 years), with American Indian/Alaska Native persons having five times the incidence of White persons.
Conclusions:
- Tularemia incidence has increased, potentially due to actual infections or improved detection.
- Tailored prevention education and enhanced healthcare provider training, especially for tribal populations, are essential for reducing incidence and mortality.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
116
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
116
Steps in Outbreak Investigation
89
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
89
Pulmonary Tuberculosis V
143
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
143
Pulmonary Tuberculosis III
253
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
253
Pulmonary Tuberculosis II
187
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
187
Vaccinations
42.9K
Overview
42.9K

